# Pharmacokinetic Study of Rezafungin in Patients With Suspected Intra-Abdominal Candidiasis

> **NCT06985758** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal** · enrollment: 20 (estimated)

## Conditions studied

- Candidal Peritonitis

## Interventions

- **DRUG:** Rezafungin 400mg followed by weekly doses of intravenous Rezafungin 200mg

## Key facts

- **NCT ID:** NCT06985758
- **Lead sponsor:** Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-11
- **Final completion:** 2026-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06985758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06985758, "Pharmacokinetic Study of Rezafungin in Patients With Suspected Intra-Abdominal Candidiasis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06985758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*